Yusuke Suenaga

Chiba, 2608717, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.

Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 18, 2026

PhiKan 083 Inhibits MYCN Expression in Liver Cancer Cells Independent of p53 Pathways.

PhiKan 083 Inhibits MYCN Expression in Liver Cancer Cells Independent of p53 Pathways.

Journal: ACS pharmacology & translational science

Published: January 26, 2026

Chemical Screening of RIKEN Natural Products Depository Identified a MYCN Expression Inhibitor Partially through HGF-MET Signaling Pathway.

Chemical Screening of RIKEN Natural Products Depository Identified a MYCN Expression Inhibitor Partially through HGF-MET Signaling Pathway.

Journal: ACS chemical biology

Published: January 21, 2026

FIR/PUF60: Multifunctional Molecule Through RNA Splicing for Revealing the Novel Disease Mechanism and Effective Individualized Therapies.

FIR/PUF60: Multifunctional Molecule Through RNA Splicing for Revealing the Novel Disease Mechanism and Effective Individualized Therapies.

Journal: International journal of molecular sciences

Published: December 08, 2025

CCB-4 and its sugar complexes induce mitotic catastrophe and p53-independent apoptosis through caspase-2 elevation and suppression of c-Myc in T47D cells.

CCB-4 and its sugar complexes induce mitotic catastrophe and p53-independent apoptosis through caspase-2 elevation and suppression of c-Myc in T47D cells.

Journal: Journal of advanced pharmaceutical technology & research

Published: November 07, 2025

Editorial: Molecular mechanisms and treatment of MYCN-driven tumors, volume II.

Editorial: Molecular mechanisms and treatment of MYCN-driven tumors, volume II.

Journal: Frontiers in oncology

Published: August 22, 2025

Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Journal: Nature

Published: July 27, 2025

CCA-1.1 Destabilizes MYC proteins to induce irreversible anti-proliferative effects in hepatocellular carcinoma.

CCA-1.1 Destabilizes MYC proteins to induce irreversible anti-proliferative effects in hepatocellular carcinoma.

Journal: Medical oncology (Northwood, London, England)

Published: July 03, 2025

Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Journal: Nature

Published: February 13, 2025

cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis.

cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis.

Journal: Nature communications

Published: November 18, 2024

Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation.

Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation.

Journal: Oncology reports

Published: October 11, 2024

Discovery of pyroptosis-inducing natural products in neuroblastomas: computational studies with experimental validation.

Discovery of pyroptosis-inducing natural products in neuroblastomas: computational studies with experimental validation.

Journal: BMC complementary medicine and therapies

Published: September 26, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026